Circulating anti-Müllerian hormone and breast cancer risk: A study in ten prospective cohorts
<p>A strong positive association has been observed between circulating anti-Müllerian hormone (AMH), a biomarker of ovarian reserve, and breast cancer risk in three prospective studies. Confirming this association is important because of the paucity of biomarkers of breast cancer risk in preme...
Հիմնական հեղինակներ: | Ge, W, Clendenen, TV, Afanasyeva, Y, Koenig, KL, Agnoli, C, Brinton, LA, Dorgan, JF, Eliassen, AH, Falk, RT, Hallmans, G, Hankinson, SE, Hoffman-Bolton, J, Key, TJ, Krogh, V, Nichols, HB, Sandler, DP, Schoemaker, MJ, Sluss, PM, Sund, M, Swerdlow, AJ, Visvanathan, K, Liu, M, Zeleniuch-Jacquotte, A |
---|---|
Ձևաչափ: | Journal article |
Հրապարակվել է: |
Wiley
2018
|
Նմանատիպ նյութեր
-
Breast cancer risk prediction in women aged 35–50 years: impact of including sex hormone concentrations in the Gail model
: Tess V. Clendenen, և այլն
Հրապարակվել է: (2019-03-01) -
Anti-Müllerian hormone and risk of ovarian cancer in nine cohorts
: Jung, S, և այլն
Հրապարակվել է: (2017) -
Anti-Mullerian hormone and endometrial cancer: a multi-cohort study
: Fortner, RT, և այլն
Հրապարակվել է: (2017) -
Temporal reproducibility of IgG and IgM autoantibodies in serum from healthy women
: T. V. Clendenen, և այլն
Հրապարակվել է: (2022-04-01) -
Genetic Polymorphisms in Vitamin D Metabolism and Signaling Genes and Risk of Breast Cancer: A Nested Case-Control Study.
: Tess V Clendenen, և այլն
Հրապարակվել է: (2015-01-01)